Meeder Asset Management Inc Palatin Technologies Inc Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.27 - $0.5 $1,250 - $2,316	-4,632 Reduced 16.28%	23,818 $6,000
Q1 2022 May 10, 2022	BUY	$0.37 - $0.54 $10,526 - $15,363	28,450 New	28,450 $12,000
Q4 2021 Feb 11, 2022	SELL	$0.34 - $0.86 $9,073 - $22,949	-26,686 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$0.68 - $1.25 $18,146 - $33,357	26,686 New	26,686 $18,000
Q4 2020 Feb 09, 2021	SELL	$0.38 - $0.78 $10,141 - $20,815	-26,687 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.36 - $0.79 $11,560 - $25,368	-32,112 Reduced 54.61%	26,687 $11,000
Q3 2019 Oct 17, 2019	BUY	$0.78 - $1.09 $39,254 - $54,855	50,326 Added 593.96%	58,799 $53,000
Q2 2019 Aug 05, 2019	BUY	$0.98 - $1.64 $2,548 - $4,264	2,600 Added 44.27%	8,473 $10,000
Q3 2018 Nov 02, 2018	BUY	$0.88 - $1.1 $5,168 - $6,460	5,873 New	5,873 $0

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.